Decapentaplegic/DPP Antibody (146609) [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB159H

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Asp457-Arg588 (Gln473His, Pro474Ala)
Accession # NP_722813.1
Specificity
Clonality
Host
Isotype
Applications for Decapentaplegic/DPP Antibody (146609) [HRP]
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: Decapentaplegic/DPP
Decapentaplegic (Dpp) is one of at least five TGF-beta superfamily ligands identified in the Drosophila genome. Dpp, a functional orthologue of mammalian BMP-2 and BMP-4, is a morphogen and plays an essential role in Drosophila development. Dpp regulates embryonic dorsal-ventral polarity and is required for gut morphogenesis and outgrowth and patterning of imaginal disks. Cellular responses to Dpp are mediated by the ligand-induced formation of heteromeric complexes of the Drosophila type I, Thick Veins (Tkv), and type II, Punt, serine/threonine kinases. The activated receptor complex induces the phosphorylation of the prototypical Smad, Mad, and subsequent translocation of the Mad-Medea complex to the nucleus where they regulate the transcription of target genes. Secreted extracellular Dpp antagonists, including the short-gastrulation (Sog) and twisted gastrulation (TSG), bind to Dpp and regulate its availability.
Alternate Names
Additional Decapentaplegic/DPP Products
Product Documents for Decapentaplegic/DPP Antibody (146609) [HRP]
Product Specific Notices for Decapentaplegic/DPP Antibody (146609) [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.